But it takes about 3 months for Dupixent to be fully cleared from your system. But it’s possible that healthcare professionals may prescribe this drug off-label for other conditions.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The label update is based on data from the late-stage LIBERTY-AD-HAFT study, which evaluated the efficacy and safety of Dupixent in 133 adult and adolescent (aged 12 to 17 years) patients with ...

The US Food and Drug Administration (FDA) has accepted for review the resubmitted supplemental Biologics License Application (sBLA) for Sanofi and Regeneron’s Dupixent (dupilumab) in chronic ...